Tag: cannabis stocks

Although near-term weakness exists in the cannabis stocks, we expect Cannabis 2.0 products or cannabis-derived products could act as a catalyst.

Last week, Aurora Cannabis (ACB) announced an early conversion privilege for debenture holders with a due date of March 9, 2020.

California’s legal cannabis market spending will rise from $3.1 billion in 2019 to $7.2 billion in 2024. The market could be $11.0 billion by 2030.

So far, November has been tough for the cannabis sector. Most cannabis companies have reported lower-than-expected earnings.

Aurora Cannabis reported its third-quarter results after the market closed on November 14. Despite some positives, it fell 18% on November 15.

This week has been tough for the cannabis sector. Cronos Group and Canopy Growth reported lower-than-expected earnings, and the sector ETFs dropped.

Yesterday, Canopy Growth (CGC) and Aurora Cannabis reported their earnings. Let's look at the valuation multiples of these two prominent cannabis players.

It’s been quite the whipsaw week for cannabis stocks, to put it mildly. First, there was the “Drake spike.” Then came the earnings disappointments.

After Aurora Cannabis's Q1 earnings release on Thursday, its stock closed at $3.29 on the NYSE, 7.32% lower than the previous day.

For the last few months, there's been weakness in the cannabis sector. Investors were hoping for Canopy Growth and Aurora Cannabis to bring some relief.